Fri, January 11, 2019
Thu, January 10, 2019
Wed, January 9, 2019
Tue, January 8, 2019
Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018

David Lewis Maintained (ABT) at Buy with Increased Target to $85 on, Jan 2nd, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-85-on-jan-2nd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $82 to $85 on, Jan 2nd, 2019.

David has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with David


  • Matt Miksic of "Credit Suisse" Initiated at Buy and Held Target at $82 on, Tuesday, December 18th, 2018
  • Isaac Ro of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $81 on, Friday, November 30th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $79 on, Thursday, October 18th, 2018
  • Matthew Taylor of "Barclays" Initiated at Buy and Held Target at $80 on, Tuesday, October 16th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018